產(chǎn)品供應(yīng)(6S)-6-[5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基]-5-氮雜螺[2.4]庚烷-5-羧酸叔丁酯

  • 發(fā)布日期：2020-07-20
  • 有效期限：30天
上海贏瑞生物醫(yī)藥科技有限公司 VIP
回上一頁 在線詢盤 打印本頁
詳細(xì)信息
  • ;(6S)-6-[5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基]-5-氮雜螺[2.4]庚烷-5-羧酸叔丁酯;雷迪帕維中間體;(6S)-6-(5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮雜螺(2.4)庚烷-5-羧酸叔丁酯;(S)-5-叔丁氧羰基-6-(5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮雜螺[2.4]庚烷;雷迪帕韋中間體5;(S)-6-(5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮雜螺[2.4]庚烷-5-羧酸叔丁酯;
  • (6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester
  • ;(S)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;(6S)-tert-butyl-6-(5-(7-bromo-9,9-difluo-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carbosylate;(S)-tert-butyl6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;ledipasvir intermediate;(6s)-6-(5-(7-bromo-9,9-difluoro-9h-fluoren-2-yl)-1h-imidazol-2-yl)-5-azaspiro(2.4)heptane-5-carboxylicacid 1,1-dimethyl ethylester;(6S)-tert-butyl-6-(5-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-1H-iMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;(6S)-Tert-butyl-6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imMidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylester;

免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對此不承擔(dān)任何保證責(zé)任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。